Global Innovative Platforms GIPL
OTC GIPL
$0.50 +0.00 (+0.00%)
At close: Oct 14, 2026 · 4:00 PM EDT

Global Innovative Platforms (GIPL) Receivables - Net (2026)

Updated

Global Innovative Platforms (GIPL) recorded Receivables - Net of $14,700 in fiscal Q3 2026 (quarter ended Jun 30, 2026), down 18.3% from the prior quarter.

Analysis

Global Innovative Platforms (GIPL) Receivables - Net (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,133.43 Bn 1,102.02 Bn 19.71 Bn
2 Johnson & Johnson 615.31 Bn 533.83 Bn 17.26 Bn
3 AbbVie 505.93 Bn 479.05 Bn 12.70 Bn
4 Merck 367.07 Bn 321.44 Bn 12.21 Bn
5 Novartis Ag 297.69 Bn 261.68 Bn 11.24 Bn
6 Astrazeneca 261.59 Bn 235.28 Bn 12.86 Bn
7 Amgen 236.28 Bn 191.68 Bn 7.24 Bn
8 Gilead Sciences 190.31 Bn 164.51 Bn 6.22 Bn
9 Pfizer 170.69 Bn 117.33 Bn 10.94 Bn
10 Global Innovative Platforms 24.88 Mn 24.27 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 14,700.00
Mar 31, 2026 18,000.00
API Access

Global Innovative Platforms Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=GIPL&period=max&api_key=YOUR_API_KEY